
Quarterly report 2025-Q2
added 07-30-2025
Entegris Financial Ratios 2011-2026 | ENTG
Annual Financial Ratios Entegris
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
55.4 | 89.2 | 73.3 | 45.7 | 45.0 | 28.3 | 19.7 | 55.5 | 27.4 | 20.4 | 229.6 | 19.9 | 19.9 | 10.3 |
P/S |
5.0 | 4.6 | 4.7 | 8.1 | 7.1 | 4.5 | 3.1 | 3.5 | 2.3 | 1.5 | 1.9 | 2.1 | 1.9 | 1.7 |
EPS |
1.9 | 1.2 | 1.5 | 3.0 | 2.2 | 1.9 | 1.7 | 0.6 | 0.7 | 0.6 | 0.1 | 0.5 | 0.5 | 0.9 |
EV (Enterprise Value) |
15.9 B | 15.7 B | 14.7 B | 18.7 B | 14.2 B | 8.21 B | 5.58 B | 5.08 B | 3.06 B | 2.14 B | 2.43 B | 1.22 B | 1.16 B | 1.12 B |
EBITDA per Share |
4.78 | 4.48 | 4.32 | 5.1 | 3.33 | 2.26 | 2.52 | 2.02 | 1.42 | 1.18 | 0.41 | 0.732 | 0.794 | 1.02 |
EV/EBITDA |
27.1 | 30.7 | 25.5 | 14.7 | 16.7 | 14.2 | 11.8 | 38.3 | 10.8 | 9.5 | 7.3 | |||
PEG |
2.91 | 5.68 | 3.68 | 1.45 | 2.9 | 2.69 | 0.11 | -4.25 | 1.33 | 0.02 | -2.57 | 2.57 | -0.44 | 0.24 |
P/B |
1.9 | 1.8 | - | 5.9 | 9.6 | 6.2 | 4.7 | 4.8 | 3.0 | 2.0 | 2.4 | 2.0 | 2.0 | 2.1 |
P/CF |
25.7 | 25.0 | 42.1 | 46.7 | 42.1 | 26.7 | 23.5 | 23.6 | 18.7 | 33.4 | 26.4 | 30.2 | 21.0 | 10.1 |
ROE % |
7.93 | 5.30 | 6.49 | 23.87 | 21.38 | 21.86 | 23.79 | 8.57 | 10.80 | 10.00 | 1.05 | 9.85 | 9.91 | 20.36 |
ROA % |
3.49 | 2.05 | - | 12.82 | 10.11 | 10.13 | 10.39 | 4.30 | 5.72 | 4.84 | 0.45 | 8.51 | 8.48 | 17.09 |
ROCE % |
14.46 | 14.64 | 14.92 | 32.20 | 15.12 | 10.63 | 14.29 | 14.35 | 10.82 | 7.96 | 1.34 | 11.88 | 13.84 | 20.07 |
Current Ratio |
- | - | - | - | 4.1 | 3.5 | 3.8 | 3.6 | 3.1 | 4.0 | 2.9 | 6.3 | 6.2 | 5.4 |
DSO |
- | - | - | - | 51.9 | 53.8 | 52.3 | 49.9 | 51.5 | 47.7 | 58.4 | 53.6 | 47.9 | 52.2 |
DIO |
129.5 | - | - | 117.7 | 117.1 | 119.2 | 117.8 | 98.6 | 100.5 | 103.5 | 101.7 | 86.0 | 88.6 | 81.0 |
DPO |
34.1 | - | - | 31.3 | 29.5 | 35.0 | 40.9 | 34.2 | 33.7 | 22.1 | 35.8 | 35.1 | 32.5 | 26.4 |
Operating Cycle |
129.5 | - | - | 117.7 | 169.0 | 172.9 | 170.1 | 148.4 | 151.9 | 151.2 | 160.1 | 139.6 | 136.5 | 133.2 |
Cash Conversion Cycle |
95.5 | - | - | 86.4 | 139.5 | 138.0 | 129.2 | 114.2 | 118.2 | 129.2 | 124.3 | 104.5 | 104.0 | 106.8 |
All numbers in USD currency
Quarterly Financial Ratios Entegris
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.35 | 0.42 | 0.51 | 0.45 | 0.3 | - | 0.22 | 1.32 | -0.59 | - | -0.5 | 0.73 | 0.93 | 0.87 | 0.87 | 0.66 | 0.63 | 0.64 | 0.59 | 0.51 | 0.45 | 0.43 | 0.3 | 0.92 | 0.24 | 0.58 | 0.34 | 0.38 | 0.41 | -0.2 | 0.29 | 0.28 | 0.23 | 0.18 | 0.16 | 0.23 | 0.12 | 0.13 | 0.17 | 0.17 | 0.11 | 0.07 | -0.01 | -0.11 | 0.1 | 0.15 | 0.13 | 0.14 | 0.12 | 0.08 | 0.13 | 0.16 | 0.13 | 0.3 | 0.16 | 0.24 | 0.22 |
EBITDA per Share |
1.04 | 1.14 | 1.21 | 1.18 | 1.08 | - | 1.12 | 2.15 | 0.4 | - | 0.54 | 1.25 | 1.38 | - | 1.53 | 1.11 | 1.01 | - | 1.25 | 1.01 | 0.75 | - | 0.8 | 0.67 | 0.47 | - | 0.82 | 0.75 | 0.67 | - | 0.73 | 0.62 | 0.46 | - | 0.54 | 0.52 | 0.31 | - | 0.51 | 0.47 | 0.29 | - | 0.28 | -0.03 | 0.19 | - | 0.33 | 0.29 | 0.2 | - | 0.35 | 0.33 | 0.24 | - | 0.35 | 0.41 | 0.33 |
ROE % |
7.16 | 7.09 | 6.40 | 5.23 | 9.19 | 4.10 | 1.73 | -1.62 | -2.31 | 9.74 | 16.64 | 26.30 | 26.95 | 25.98 | 25.36 | 23.81 | 22.89 | 21.38 | 20.03 | 17.92 | 24.24 | 23.08 | 26.13 | 26.93 | 21.05 | 23.48 | 12.64 | 12.22 | 10.88 | 8.46 | 14.22 | 12.65 | 12.28 | 10.81 | 10.10 | 10.69 | 10.08 | 10.12 | 9.18 | 6.00 | 1.00 | 1.06 | 2.53 | 5.02 | 9.59 | 9.85 | 8.75 | 9.00 | 9.50 | 9.91 | 14.89 | 16.21 | 19.12 | 21.35 | 3.92 | 6.03 | 4.80 |
ROA % |
3.10 | 3.02 | 2.61 | 2.03 | 3.21 | 1.46 | 0.73 | -0.34 | 1.50 | 6.93 | 10.63 | 11.43 | 14.52 | 13.58 | 12.84 | 11.66 | 10.91 | 10.11 | 9.42 | 8.33 | 10.92 | 10.13 | 11.33 | 11.79 | 9.20 | 10.39 | 5.47 | 5.46 | 5.14 | 4.30 | 7.27 | 6.50 | 6.41 | 5.72 | 5.25 | 5.38 | 4.93 | 4.88 | 4.34 | 2.86 | 0.54 | 0.45 | 2.27 | 4.36 | 7.45 | 8.51 | 7.55 | 7.74 | 8.15 | 8.48 | 12.64 | 13.45 | 15.26 | 17.09 | 3.03 | 4.49 | 4.03 |
ROCE % |
13.55 | 14.20 | 14.41 | 14.09 | 18.36 | 11.88 | 12.36 | 9.36 | 9.64 | 17.71 | 26.36 | 34.54 | 35.44 | 25.80 | 33.54 | 32.62 | 30.32 | 20.46 | 25.17 | 22.15 | 20.26 | 14.44 | 20.71 | 22.27 | 24.70 | 21.43 | 27.39 | 27.07 | 25.62 | 17.03 | 20.90 | 18.81 | 18.02 | 12.31 | 16.35 | 16.51 | 16.26 | 12.36 | 13.07 | 9.75 | 1.72 | 0.06 | 3.22 | 5.67 | 12.28 | 9.32 | 13.23 | 13.97 | 15.04 | 12.31 | 17.09 | 17.96 | 21.01 | 18.52 | 4.78 | 7.60 | 6.14 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.9 | 65.8 | 30.2 | - |
DIO |
141.4 | 143.9 | 133.6 | 131.5 | 134.2 | - | 122.8 | 138.7 | 144.0 | - | 60.4 | 65.2 | 137.1 | - | 118.2 | 111.3 | 112.1 | - | 115.9 | 122.6 | 122.9 | - | 117.1 | 123.2 | 118.6 | - | 112.8 | 121.9 | 111.2 | - | 95.0 | 101.2 | 97.9 | - | 96.4 | 102.2 | 106.8 | - | 102.7 | 103.5 | 104.5 | - | 85.4 | 91.4 | 124.2 | - | 90.9 | 85.9 | 90.0 | - | 88.2 | 85.8 | 88.8 | - | 87.3 | 75.2 | - |
DPO |
34.3 | 38.2 | 33.0 | 28.5 | 28.9 | - | 23.8 | 26.4 | 29.8 | - | 13.8 | 16.0 | 35.5 | - | 30.9 | 27.7 | 28.7 | - | 29.2 | 30.9 | 33.4 | - | 34.3 | 36.1 | 37.9 | - | 39.1 | 42.3 | 38.6 | - | 33.0 | 35.1 | 33.5 | - | 32.4 | 34.3 | 29.5 | - | 21.9 | 22.1 | 29.3 | - | 30.1 | 32.2 | 46.3 | - | 37.1 | 35.0 | 34.8 | - | 32.4 | 31.4 | 30.8 | - | 28.4 | 24.5 | - |
Operating Cycle |
141.4 | 143.9 | 133.6 | 131.5 | 134.2 | - | 122.8 | 138.7 | 144.0 | - | 60.4 | 65.2 | 137.1 | - | 118.2 | 111.3 | 112.1 | - | 115.9 | 122.6 | 122.9 | - | 117.1 | 123.2 | 118.6 | - | 112.8 | 121.9 | 111.2 | - | 95.0 | 101.2 | 97.9 | - | 96.4 | 102.2 | 106.8 | - | 102.7 | 103.5 | 104.5 | - | 85.4 | 91.4 | 124.2 | - | 90.9 | 85.9 | 90.0 | - | 88.2 | 85.8 | 88.8 | 30.9 | 153.1 | 105.3 | - |
Cash Conversion Cycle |
107.1 | 105.7 | 100.6 | 103.0 | 105.3 | - | 99.0 | 112.3 | 114.3 | - | 46.6 | 49.1 | 101.5 | - | 87.3 | 83.6 | 83.4 | - | 86.7 | 91.7 | 89.5 | - | 82.7 | 87.1 | 80.7 | - | 73.7 | 79.6 | 72.6 | - | 62.0 | 66.0 | 64.5 | - | 64.0 | 67.9 | 77.3 | - | 80.8 | 81.5 | 75.2 | - | 55.3 | 59.2 | 78.0 | - | 53.8 | 50.8 | 55.2 | - | 55.9 | 54.3 | 58.0 | 30.9 | 124.7 | 80.8 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Entegris, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Semiconductors industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Resonant Inc.
RESN
|
- | - | $ 301 M | ||
|
ASE Technology Holding Co., Ltd.
ASX
|
$ 19.59 | -3.33 % | $ 17.8 B | - | |
|
Brooks Automation, Inc.
BRKS
|
- | -2.73 % | $ 8.41 B | ||
|
Analog Devices
ADI
|
$ 317.36 | -0.08 % | $ 157 B | ||
|
CMC Materials
CCMP
|
- | -0.45 % | $ 4.94 B | ||
|
Axcelis Technologies
ACLS
|
$ 91.51 | 0.31 % | $ 3 B | ||
|
Broadcom
AVGO
|
$ 328.84 | -1.32 % | $ 1.52 T | ||
|
Cohu
COHU
|
$ 29.38 | 1.35 % | $ 1.38 B | ||
|
Daqo New Energy Corp.
DQ
|
$ 25.09 | -5.46 % | $ 8.3 B | ||
|
Cirrus Logic
CRUS
|
$ 129.37 | -0.99 % | $ 6.87 B | ||
|
DSP Group, Inc.
DSPG
|
- | -0.05 % | $ 533 M | ||
|
Camtek Ltd.
CAMT
|
$ 153.71 | 2.35 % | $ 6.96 M | ||
|
ACM Research
ACMR
|
$ 54.54 | -2.25 % | $ 3.39 B | ||
|
Maxim Integrated Products, Inc.
MXIM
|
- | - | $ 27.7 B | ||
|
Cree, Inc.
CREE
|
- | - | $ 9.17 B | ||
|
Inphi Corporation
IPHI
|
- | -1.08 % | $ 9.25 B | ||
|
MoSys, Inc.
MOSY
|
- | -4.43 % | $ 31.9 M | ||
|
O2Micro International Limited
OIIM
|
- | - | $ 143 M | ||
|
Himax Technologies
HIMX
|
$ 8.33 | -2.23 % | $ 2.15 B | ||
|
eMagin Corporation
EMAN
|
- | -0.24 % | $ 157 M | ||
|
EMCORE Corporation
EMKR
|
- | 0.98 % | $ 28 M | ||
|
CEVA
CEVA
|
$ 22.05 | -2.04 % | $ 521 M | ||
|
Intel Corporation
INTC
|
$ 48.31 | -0.96 % | $ 219 B | ||
|
Xilinx, Inc.
XLNX
|
- | -0.75 % | $ 53.8 B | ||
|
KLA Corporation
KLAC
|
$ 1 679.76 | 3.23 % | $ 223 B | ||
|
Ichor Holdings, Ltd.
ICHR
|
$ 33.06 | 7.04 % | $ 1.08 B | ||
|
ChipMOS TECHNOLOGIES
IMOS
|
$ 38.92 | -6.68 % | $ 16.4 B | ||
|
Allegro MicroSystems
ALGM
|
$ 38.5 | 11.43 % | $ 7.23 B | ||
|
Lam Research Corporation
LRCX
|
$ 247.02 | 3.1 % | $ 318 B | ||
|
FormFactor
FORM
|
$ 72.81 | 0.35 % | $ 5.63 B | ||
|
MaxLinear
MXL
|
$ 19.11 | -0.16 % | $ 1.6 B | ||
|
AXT
AXTI
|
$ 16.29 | -3.21 % | $ 695 M | ||
|
NVE Corporation
NVEC
|
$ 71.65 | -0.87 % | $ 346 M | ||
|
Nova Measuring Instruments Ltd.
NVMI
|
$ 493.61 | 1.32 % | $ 14.4 M | ||
|
Universal Display Corporation
OLED
|
$ 115.25 | -2.36 % | $ 5.48 B | ||
|
IPG Photonics Corporation
IPGP
|
$ 92.35 | -0.1 % | $ 4.09 B | ||
|
Amtech Systems
ASYS
|
$ 17.21 | -5.85 % | $ 245 M | ||
|
GSI Technology
GSIT
|
$ 7.24 | -7.77 % | $ 185 M | ||
|
Photronics
PLAB
|
$ 35.03 | -2.53 % | $ 2.12 B | ||
|
inTEST Corporation
INTT
|
$ 9.39 | 0.43 % | $ 112 M | ||
|
Atomera Incorporated
ATOM
|
$ 3.02 | 7.68 % | $ 82.2 M | ||
|
Power Integrations
POWI
|
$ 46.72 | -0.11 % | $ 2.65 B | ||
|
Applied Optoelectronics
AAOI
|
$ 38.67 | -14.5 % | $ 1.61 B | ||
|
Microchip Technology Incorporated
MCHP
|
$ 78.93 | -1.68 % | $ 42.8 B | ||
|
nLIGHT
LASR
|
$ 46.89 | 1.98 % | $ 2.25 B | ||
|
Monolithic Power Systems
MPWR
|
$ 1 176.05 | 1.23 % | $ 57.2 B | ||
|
Everspin Technologies
MRAM
|
$ 13.19 | 0.57 % | $ 285 M | ||
|
Rambus
RMBS
|
$ 119.79 | -3.74 % | $ 12.9 B | ||
|
Advanced Micro Devices
AMD
|
$ 250.46 | -0.9 % | $ 406 B |